Protagonist Therapeutics Director Selick Sells $2.52 Million in Shares
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowSelick, a director at Protagonist Therapeutics, has sold shares worth $2.52 million. This sale may influence investor sentiment and market perceptions of the company's future performance. Such insider selling can be interpreted as a signal concerning the company's direction and financial health. As of October 2023, details on the number of shares sold and the price per share were not disclosed.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
